STOCK TITAN

RenX Enterprises (RENX) SEC Filings

RENX NASDAQ

Ticker history: SGD became RENX (RenX Enterprises Corp.) on . Earlier news and filings retain their original names and dates. View SGD history.

The RenX Enterprises Corp. (RENX) SEC filings page on Stock Titan is designed to present the company’s regulatory disclosures in a structured format, with AI-powered tools that help explain the content of each document. While no specific filings are listed in the provided data, RenX’s public statements describe a business that combines environmental processing operations with legacy real estate asset monetization, and its SEC reports are expected to reflect these activities.

RenX identifies itself as a real estate development and environmental solutions company. According to its disclosures, primary operations include a permitted 80+ acre organics processing facility in Myakka City, Florida, where the company processes source-separated green waste, as well as a logistics platform that provides transportation services across biomass, solid waste, and recyclable materials. In SEC filings such as annual reports on Form 10-K and quarterly reports on Form 10-Q, investors typically look for narrative and financial details related to these operations, including descriptions of the organics processing facility, logistics services, and renewable materials initiatives.

The company also reports a focus on expanding into sustainable, higher-margin potting media and soil substrates through advanced milling technology, along with efforts to monetize a legacy real estate asset portfolio. Regulatory filings often provide additional context on such strategies, including risk factors, segment descriptions, and information about property holdings and related transactions.

On Stock Titan, RenX filings are accompanied by AI-generated summaries intended to clarify key points in lengthy documents. Users can review forms such as 10-K and 10-Q when available, as well as current reports on Form 8-K that may describe material events like equipment purchases, debt restructurings, or property transfers, and ownership reports on Form 4 that disclose insider transactions, where applicable.

Rhea-AI Summary

RenX Enterprises Corp. is seeking stockholder approval for three issuances of common stock upon conversion: 4,779,333 shares for Series C preferred stock, 960,667 shares for Series D preferred stock, and up to 2,136,728 shares for a senior convertible note. The note estimate assumes 10% interest for 12 months and conversion at the floor price; the preferred-stock share counts may increase with dividends or conversion-price adjustments.

Other proposals would increase authorized common shares from 500,000,000 to 525,000,000 and permit a Board-selected reverse split ratio from 1-for-5 to 1-for-25, subject to stockholder approval and a further Board decision. At the maximum described, Series C preferred-stock conversion and warrant shares could represent approximately 60.9% of post-issuance common shares, and the Series D shares and warrant approximately 23.8%; both figures exclude dividend-related additions. The Board recommends voting for all six proposals, including adjournment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

RenX Enterprises Corp. reported revenue of $12.7 million for the nine months ended September 30, 2026, versus $4.9 million a year earlier, while net loss was $26.0 million versus $12.3 million. Third-quarter revenue was $4.5 million, compared with $3.5 million, and net loss was $8.7 million versus $4.4 million.

Operating cash use was $7.4 million, compared with $425,565 in 2025. At September 30, 2026, cash was $201,379; current assets were $3.16 million and current liabilities were $27.90 million. RenX reported negative working capital of $24,741,590 and said these conditions raise substantial doubt about its ability to continue as a going concern. Total debt was $24.03 million, including $21.08 million in current maturities.

April private-placement closings generated approximately $5.7 million and $5.4 million in net proceeds; the second closing proceeds were used to repay $5.1 million of February notes. Further closings of up to $87 million are subject to conditions and mutual agreement, and the company said there is no assurance they will occur.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.69%
Tags
quarterly report
-
Rhea-AI Summary

RenX Enterprises Corp. (RENX) is named in a Schedule 13G reporting beneficial ownership of its common stock by Anson Funds Management LP, Anson Management GP LLC, Tony Moore, Anson Advisors Inc., Amin Nathoo and Moez Kassam. Each of the six reporting persons reports 162,636 shares, or 6.2% of the class; these are overlapping reports on the same shares held by private funds advised by Anson Funds Management LP and Anson Advisors Inc. The reporting persons report shared voting and dispositive power over the shares, with zero sole voting and dispositive power. The reported position relates to September 30, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.59%
Tags
ownership
Rhea-AI Summary

RenX Enterprises Corp. reported third-quarter 2026 revenue of $4.483 million, up 27.5% year over year and 5.3% sequentially. Gross margin was 34.3%, versus 31.9% in Q2. Net loss was $8.690 million, or $(3.27) per share, compared with $8.019 million in Q2. Interest expense was $5.661 million, including approximately $4.1 million of non-cash amortization of debt discount and issuance costs.

EBITDA loss narrowed to $2.304 million from $4.403 million in Q2, a reported 68% improvement from Q1. Adjusted EBITDA loss was $2.243 million, versus $1.930 million in Q2. Logistics recorded $416,000 of operating income for a third consecutive profitable quarter; Compost Sales had a $766,000 operating loss, narrowed 16% sequentially.

Microtec mill construction was completed in late October 2026. RenX expects energization before the end of 2026, with first production targeted for January 2027 and a phased ramp planned through the first half of 2027. Through September 30, 2026, it had invested approximately $1.8 million of the approximately $2.0 million program budget. RenX says its 2027 objectives require additional capital, which may not be available on acceptable terms, and cites restrictive covenants under recent private-placement agreements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.59%
Tags
current report
-
Rhea-AI Summary

RenX Enterprises Corp. exchanged $1,022,971.22 of principal and accrued interest under a prior senior convertible note for a new senior convertible note with $1,037,283.93 principal and a warrant to purchase 644,944 common shares. The securities were issued on November 2, 2026, and the prior note and its outstanding debt were cancelled.

The unsecured new note bears 10% annual interest and matures 12 months after issuance, subject to extension in certain circumstances. It initially converts at the holder’s option at $2.895 per share. After stockholder approval, the alternate conversion price is the greater of $0.534 or 92% of the lowest volume weighted average price during the prior 10 trading days. Conversions and warrant exercises are subject to a Nasdaq exchange cap and a 4.99% beneficial ownership limit, or 9.99% at the holder’s option.

The warrant is immediately exercisable at $2.67 per share for six years from issuance. The company agreed to hold a stockholder meeting as soon as practicable and no later than 120 days after the agreement’s effective date; if approval is not obtained within 180 days despite reasonable best efforts, it must hold another meeting within 120 days thereafter.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.72%
Tags
current report
-
Rhea-AI Summary

RenX Enterprises Corp. (RENX) director Jeffrey C. Tweedy received a grant of 8,318 stock options on October 13, 2026, for 8,318 shares of common stock. The options have an exercise price of $1.54 per share and expire October 12, 2036. They vest pro rata monthly over six months starting November 13, 2026, subject to his continued service through each vesting date. His reported option holdings after the grant were 8,318.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
insider
Rhea-AI Summary

RenX Enterprises Corp. director Christopher Melton received a grant of 8,254 stock options on October 13, 2026, to acquire 8,254 shares of Common Stock. The options have an exercise price of $1.54 per share and expire October 12, 2036. They vest pro rata monthly over six months beginning November 13, 2026, subject to his continued service through each vesting date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
insider
-
Rhea-AI Summary

RenX Enterprises Corp. (RENX) director J. Scott Magrane received a grant of 8,294 stock options on October 13, 2026. The options cover 8,294 common shares, have a $1.54 exercise price, and expire October 12, 2036. They vest pro rata monthly over six months beginning November 13, 2026, subject to continued service through each vesting date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
insider
-
Rhea-AI Summary

RenX Enterprises Corp. director Bjarne Erik Siwert Borg acquired 8,500 stock options on October 13, 2026. The options are for common stock, carry an exercise price of $1.54 per share, and vest pro rata monthly over six months beginning November 13, 2026, subject to his continued service through each vesting date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
insider
Rhea-AI Summary

RenX Enterprises Corp. director Peter G. DeMaria received an award of 8,294 stock options covering 8,294 common shares on October 13, 2026. The options have a $1.54-per-share exercise price and vest pro rata monthly over six months beginning November 13, 2026, subject to his continued service through each vesting date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
insider

FAQ

How many RenX Enterprises (RENX) SEC filings are available on StockTitan?

StockTitan tracks 50 SEC filings for RenX Enterprises (RENX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for RenX Enterprises (RENX)?

The most recent SEC filing for RenX Enterprises (RENX) was filed on November 20, 2026.